Product List | ||
API & Intermedia | ||
Product Name | Cas No. | Applicatio |
II-methylindoline | 6872-06-6 | Indapamide scriptor medium |
I-amino-II, methylindolinehydrochloride | 102789-79-7 | |
IV-chloro-III-sulphamoylbenzoic acidum | 1205-30-7 | |
IV-chloro-III-sulfamoylbenzoylchloride | 70049-77-3 | |
1- (III-methoxyphen) piperazine | 16015-71-7 | Letermovir est medium |
1- (III-methoxyphenh) piperazine dihydrochloride | 6968-76-9 | |
II-Bromus-VI, Fluorobenzenamine | 65896-11-9 | |
(II-methxy-5 (trifloromethyl) aniline) | 349-65-5 | |
II-propenoic acidum, 3- (II-amino-III-fluorophenyl) -, yster Ester (2e) - | 690664-20-1 | |
IV-Quinezolineacetic Acidum, VIII, fluoro, 1,2,3,4-Tetrahydro, 3- [II-IV-5- (trifloromethyl) Phenyl] -2-Oxo-, Methyl Esther | 917389-21-0 | |
II-propenoic acidum, 3- [III-fluoro-II - [(phreneticis) amino] Phenyl] -, Methyl Ester, (2e) - | 1791412-01-5 | |
I-methylindole | AZD9291 (Osimertinib) 's medium | |
N, N, N'-trimethylethylenediamine | 142-25-6 | |
3 (II-chloropyrimidin-IV yl) -1-methylindole | 1032452-86-0 | |
IV-fluoro-II-methoxy-V, nitroaniline | 1075705-01-9 | |
1- (I-ethoxyethyl) -4- (4,4,5,5-Tetramethyl, 1,3,2 -DioXaborolan-II-YL) -1H-Pyrazole | 1029716-44-6 | Ruxolitinib scriptor medium |
IV-Chloro-7h-Pyrrolo [2,3-D] Pyimidine | 3680-69-1 | |
III-cyclopentylacrylactonitrile | 591769-05-0 | |
Cyclopentanecarbaldehyde | 872-53-7 | |
II-amino-3,5, Dibromopyrazine | 24241-18-7 | Upadacitinib est medium |
16713-66-9 | ||
3,3, tetramethyleneglutarimide | 1075-89-4 | Buspirone scriptor medium |
1- (II-Pyrimidinyl) piperazine | 20980-2222-7 | |
V, methyl, 1,3,4, oxadiazole-II-carboxylic acidum potassium sal | 88504-28-7 | Raltegravir scriptor medium |
Methyl 2- [I - [[(Benzyloxy) Carbonyl] amino] -1 -1-methylethyl] -5,6, dihydroxyrimidine, IV-carboxylate | 519032-08-7 | |
V, Methyl, II (1h) -Pyridinone | Pirfenidone est medium | |
((3aR,4R,6R,6aR)-6-(4-(hydroxyamino)-2-oxopyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate | 2346620-55-9 | Molnupiravir scriptor medium |
I-Bromus-III-methyl-II-butten | 870-63-3 | Sofalcone scriptor medium |
Tianeptine sodium sal | 30123-17-2 | |
-VII-metthoxy-I-tetralone | 6836-19-7 | Agomlattine scriptor medium |
4 (IV-Bromo-3 (hydroxymethyl) phenoxy) Benzonitile | 906673-45-8 | Crisaborole scriptor medium |
Methyl 4,6, dichloropyridazine-III-carboxylate | 372118-01-9 | DeUCRAVACITINIB scriptor medium |
3680-69-1 | Tofacitinib, Ruxolitinib scriptor medium | |
(R) - (+) - II-tetrahydrofuroic acidum | 87392-05-0 | |
Methyl IV-chloro-IV-oxobutanoate | 1490-25-1 | Medius |
2,5,6, tetrachloropyridine | ||
P-TolynhydrazinehorhLoride | 637-60-5 | |
Phenylhydrazine hydrochloride | 59-88-1 | |
I-Bromus-IV-iodobenzene | 589-87-7 | |
IV-iodonitrobenzene | 636-98-6 | |
II-acetyl, IV-methylpyridine | 59576-26-0 | Alpellaib intermedia |
1,1,1, trifluaro-2- (IV-methylpytridin-II-yl) propanol | 1396893-43-8 | Alpellaib intermedia |
IV-methyl, 2- (1,1,1, trifluaro-II-Dimethyl, II-ethyl) Pyrtride | 1378865-93-0 | Alpellaib intermedia |
IV-chloropyrrolidine | 3680-69-1 | |
479633-63-1 | ||
1062580-52-2 | ||
(2r, 3r) -2,3-bis [(IV-methylbenzoyl) oxy] acidum acid et (3r, 4R) - n: IV-1- (Phenylmethyl) -3, Piperidine Amine | 477600-71-8 | |
Fumarate vorolazan | 1260141-27-2 | Vonolazan medium |
II - (II - (II-fluorobenzene) - II-oxyethyl) proponionitile | 312307-38-3 | |
II-chloro-V - (II, fluorophenyl) - 1h-pyrrole-III-acatholitrile | 1240948-72-4 | |
V - (II, fluorophenyl) - 1h-pyrrole-III, acathetonitrile | 1240948-77-9 | |
881674-56-2 | ||
881677-11-8 | ||
V - (II-Fluorophenyl) - N-methyl, I - (III-pyridylsulfonyl) - 1h-pyrrol-III-methylamine | 881681-00-1 | |
16133-25-8 | ||
28092-52-6 | ||
E6 Porphyrin | 19660-77-6 | |
(S) - (+) -2,2-Dimethyl, 1,3-dioxocyclopent-IV-methylbenzenzenzenfonate | 23735-43-5 | |
Biluvadine Pentapeptide | 1450625-21-4 | Biluvadine Pentapeptide medium |
III, chlorophenylacetone | 936-59-4 | DAPOX |
1- [3 (Acetxy) Phenyl] -2, Bromoethanone | 38396-89-3 | |
2035090-53-8 | ||
VI, Bromus-VIII-Chloro, 3,4-Dihydronaphthalene-II (1h) - unum | 1337847-33-2 | |
Ethyl chlorofluoroacetate | 401-56-9 | |
4857--6--1 | ||
-VI-Bromus-VIII-fluoro, 3,4-dihydronaphthalene-II (1h) - unum | 1337857-08-5 | |
N-acetyl-3- (3,5-difluorophenyl) - DL Alanine | 266360-52-5 | |
146464-90-6 | ||
II, mercaptopyridine | 2637-34-5 | |
III, mercaptopyridine | 109-00-2 | |
3,5, Dimethyl, II-Pyrrolaldehyde | 2199-58-8 | |
3,5, Dimethyl, IV-Nitropyrrule-II-formaldehyde | 40236-20-2 | |
(3s) -3- [4 [(II-chloro-V-iodophenyl) Methyl] phenoxy] tetrahydrofurran | 915095-94-2 | |
IV-cyano-II-methoxybenzaldehyde | 21962-45-8 | |
IV-Amino-V, Methyl, II-hydroxypytridine | 95306-64-2 | |
XVII-amino-X-oxy, 3,6.12,15, tetraolaa, IX-IX Azaheptadecanoic acidum | 1143516-05-5 | |
L-prolica Tert Butyl Ester | 2812-46-6 | |
S-III-Aminoquinine Cycloamine Hydrochloride | 119904-90-4 | Palonosetron |
85977-52-2 | ||
5,6,7,8, tetrahydro-I-napthoic acidum | 4242-18-6 | |
Sodium Bisulfite Solutio | 7631-90-5 | Reductant, conservative, decolorizer, sanitizer. |
Cyclopentanone | 120-92-3 | Photographic materiae, medicina et unguentum industria |
II-Adamantanone | 700-58-3 | Photographic materiae, pharmaceutical medium. |
II, methylindole | 95-20-5 | Medius |
2,3,3, trimethylindolenine | 1640-39-7 | |
25981-82-2 | ||
2,5-Dimethylindole | 1196-79-8 | |
1,2, Dimethylindole | ||
Indole-III-carbinol | 700-06-1 | |
Indole-III-carboxaldehyde | 487-89-8 | |
Cyclopentylpropionyl chloride | 104-97-2 | LCD materia. |
83282-91-1 | Pesticide scriptor medium | |
7acf | 80370-59-8 | |
VII-ACQ | 103122-02-7 | |
Bromoacetonitro | 590-17-0 | Paxlovid medium |
II-fluoro, 3 (trifluatoromethyl) Benzoic acidum | 115029-22-6 | |
4,4, Dimethoxy-II-Butanone | 5436-21-5 | Intermedii pro Pharma / Agri-Cham |
II-chloropyridine-III-sulfonyl chloride | 6684-06-6 | |
25984-63-8 | Febuxostat medium | |
II-cyanoisonicotin acidum Methyl Ester | 94413-64-6 | TopiroXostat medium |
3,4-Dimethoxy-II-methylpyridine, n-cadmiae | 72830-07-0 | Pantoprazole medium |
II-amino-VI, bromopyridine | 19798-81-3 | Filgotinib medium |
Methyl II-IV-IV-aminobenzoate methoxy | 27492-84-8 | Medium Lenvatinib |
Cyclopropane acetonitrul | 6542-60-5 | |
Cyclopropane acetic acidum | ||
Butyl phosphate anhydride | 163755-62-2 | Substitution of Propyl PHOSPHATE anhydride |
A-amino-2,4-difluorophenetic acidum | 240409-02-3 | Fexuprazan medium |
II-cyanoisonicotinic acidum | 161233-97-2 | TopiroXostat medium |
97509-75-6 | ||
7677-24-9 | altilium electrolytici | |
II-Cyano-V, Bromopyridine | 97483-77-7 | Tedizolid medium |
III, bromopyridine | ||
III-Bromus-IV-nitropyridine | 89364-04-5 | |
II, amino-V, bromopyridine | 1072-97-5 | Palbociclib medium |
2.3.5, trimethyl, IV-nitropyridine, n-cadmiae | Omeprazole medium | |
317319-15-6 | ||
27126-93-8 | ||
3,5 3,5, bis (trifloromethyl) Phenyl) -1H-1,2,4-triazole | 1333154-10-1 | Seginexor medium |
(Z) -3- (3,5 (3,5-bis (trifluoromethyl) Phenyl) -1h -1H-1,2,4-Triazol, I -1) Isopropyl acrylte | 1333152-22-9 | |
KPT-CCCXXX medium | 1388842-44-1 | |
Saliniso | 1393477-72-9 | |
IV-Amino-V, Methyl, II-hydroxypytridine | 95306-64-2 | Festerenone medium |
65193-87-5 | ||
IV-chloropyrrolidine | 3680-69-1 | Abrocitinib |
III-oxocyclobutanyl carboxylic acidum | 23761-23-1 | |
II-Nitro-V, Bromopyridine | 39856-50-3 | Palbociclib |
II-Nitro-V, chloropyridine | 52092-47-4 | |
VI, Nitro-1h-Indazole | 319460-85-0 | |
VI, amino-1h-indazole | 6967-12-0 | |
261953-36-0 | ||
III-Iodo-VI-Nitro-1h-Indazole | ||
2527-58-4 | ||
20054-45-9 | ||
886230-74-6 | ||
(E) -6-Nitro-3- [2- (Pyrtridin-II-YL) Ethenyl] -1- (Tetrahydro-2h-Pyrran-II-YL) -1h -1H-Indazole | ||
886230-76-8 | ||
(E) -6-iodo-3- [2- (pyrtridin-II-yl) ethenyl] -1- (Tetrahydro-2h-pyran-II-yl) -1h -1h -1H | 886230-77-9 | |
II - [(III-iodo-1h-Indazol-VI, YL) TYIO] -n-Methylbenzamide | ||
N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-yl]thio]benzamide | 885126-35-2 | |
II-Acyl, IV-chlorothiophene | 34730-20-6 | 67007-74-8 |
4 (IV-Chloro-II-Thienyl) -2, Thiazolamine | 570407-10-2 | |
I-Cyclohexylpiperazine | 17766-28-8 | |
41667-95-2 | ||
V-chloro, 6 [4 (ethoxycarbonyl) Piperidino] -Nenotinicacid | 931395-73-2 | |
4 (IV-chlorothiophen-II-yl) -5- (IV-cyclohexylpiperazin-I-yl) thiazol, II-Amine | 570407-42-0 | |
5,6, dichloro, n- [4 (IV-chlorothiophen-II-YL) -5- (IV-cyclohexylpiperazin-I-yl) thiazol, II-yl] nicotinamide | 570403-04-2 | |
570403-14-4 | ||
Avatrombopag basi | 570406-98-3 | |
II ethyl II-Cyanoacetoacetate | 65193-87-5 | 1050477-31-0 Festerenone medium |
IV-cyano-II-methoxybenzaldehyde | 21962-45-8 | |
IV-amino-II-hydroxy-V, methylpyridine | 95306-64-2 | |
(Z) -2, cyanoethyl 2- (IV-cyano-II-metoxybenzylidene) -3, oxobutanoate | 1050477-39-8 | |
Methyl IV-amino-II-metoxybenzoate | 27492-84-8 | 857890-39-2 |
IV-chloro-VII-methoxyquinolina-VI-carboxamide | 417721-36-9 | |
IV-amino-III-chlorophenol hydrochloride | 52671-64-4 | |
417716-92-8 | ||
17609-80-2 | ||
379270-35-6 | Tenofovir alafenamide fumarate medium | |
Tenofovir alafenamide | ||
4 (III, fluoro, Benzyloxy) -Benzaldehyde | Safinamide MESYLATE medium | |
Safinamide | 133865-89-1 | |
(S) -1- (2,6-dichloro-III, fluorophenyl) ethanol | CRIZotinib medium | |
(R) -5 -5-3- (1- (2,6-dichloro, III-fluorophenyl) ethoxy) pyridin-II-Amine | ||
Tert, BUTYL 4- [4,3,5 (4,4,5,5-Tetramethyl, 1,3,2-Dioxaborolan-II-YL) -1H-Pyrazol-I-YL] Piperidine-I-Carboxylate | 877399-74-1 | |
IV-hydroxy-VII-phenoxy-III-isoquinolinecarboxylic acidum Methyl Ester | 1455091-10-7 | Roxadustat medium |
85-52-9 | ||
II, aminobenzophenone | 2835-77-0 | |
II-Amino-V, Bromodibenzophophenone | 39859-36-4 | |
Orthobenzeniline | 28059-64-5 | |
II-amino-V, chlorodibenzophodone | 719-59-5 | |
II, amino-IV '- fluorobenzophodone | 3800-6-4 | |
II-Amino-IV '- Chlorobenzophophenone | 2894-51-1 | |
153684-50-5 | ||
II-Amino-V, Bromus-II '- Fluorobenzophodone | 1479-58-9 | |
III-methyl, IV-methoxycarbonyl Benzaldehyde oxime | 1261169-50-9 | Florus |
III ', V' - Dichloro, 2,2,2, Trifluorophenone | 130336-16-2 | |
II, amino-n - (2,2,2, trifluaeethyl) acetamide hydrochloride | 1171331-39-7 | |
II-methyl, IV-acetylbenzoic acidum | ||
II-Cyanophenylboron Acidum 1,3, propavanol cyclic Ester | 172732-52-4 | Perampanel medium |
5 (II-pyridyl) -1,2, dihydropyridin-II-unum | 3812333-78-9 | |
381725-50-4 | ||
Acidum phenylboronic | 98-80-6 | |
4 (IV-aminophenyl) -3-methyl, IV-oxobutyric acidum | 42075-29-6 | Levosimendan medium |
120757-13-3 | ||
IV-hydroxypyrolo [2,3-d] Pyimidine | 3680-71-5 | Tofacitinib et Ruxolitinib medium |
IV-chloropyrrolidine | 3680-69-1 | |
(3r, 4R) - N, IV-Dimethyl, 1- (Phenylmethyl) -3, Piperidine Dihydrochloride | 1062580-52-2 | |
IV-methyl, 7h-Pyrrolino [2,3-D] Pyimidine | 945950-37-8 | |
2,4-dihydroxypyridine | 626-03-9 | Palla medium |
2,4-Dichloro, III-nitropyridine | 5975-12-2 | |
2,4, dichloropyridine | 26452-80-2 | |
III, amino-2,4, dichloropyridine | 173772-63-9 | |
II-amino-V, methoxyyridine | ||
IV-amino-II-chloro-III-nitropyridine | 2789-25-5 | |
III-Chloro, IV-Cyanopyridine | 68325-15-5 | |
IV-chloro-III-nitropyridine | 13091-23-1 | |
2,6, difluorophenylboronic acidum | ||
2,6, difluorophenol | 281777-48-2 | |
VI, Chloro, 1,3, Dimethyluracil | 6972-27-6 | |
635-22-3 | ||
V-Ethoxy-II-Mercaptobenzimidazole | 55489-15-1 | |
2483-57-0 | ||
II-Bromus-III-methylbenzonitrile | ||
I, ethylpyrazole | 2817-71-2 | |
VI-Bromus Indole-II-Carboxylic Acidum | 16732-65-3 | |
142-94-9 | ||
Chloromethyl chlorosulfonic acidum Ester | ||
I-Tert Butoxycarbonyl-III-hydroxy-pyrazole, IV-carboxylic acidum ethyl Esther | 178424-17-4 | |
IV-Bromo-I-methylpyrazole | 15803-02-8 | |
I-Acetoxy, 2,3,5-Tribenzoyloyloxy-I-beta-D-Furan ReliTone | 6974-32-9 | |
1997--9--6 | ||
6642-31-5 | ||
(IV-cyclopropyl, VI, methoxyrimidin-V-yl) boric acidum | 1798304-51-4 | |
32249-35-7 | ||
121660-11-5 | ||
[II-cyclopropyl, 4 (IV-fluorophenyl) -3, quinolinyl] methyl] triphenylphosphine bromide | 154057-58-6 | |
124752-23-4 | ||
147489-06-3 | ||
571188-59-5 | Pabucilib medium | |
-VI-Bromus-II-chloro-VIII-cyclopentyl, V-yl-pyridino [2,3-d] Pyimidine | 1016636-76-2 | |
4 (1,2, BenzisothiaZol-III-YL) -1-piperazine | Lurya HCL medium | |
144010-02-6 | ||
(1r, 2r) -1,2-Cyclohexanedimethanol | 65376-05-8 | |
Bazedoxifene medium | ||
N- (II-hydroxyethyl) hexamethyleneimine | 20603-00-3 | |
II-methyl, II-oxazoline | 1120-64-5 | Nefazodone medium |
I-phenyl, 1,2,3,4, tetrahydro-issourolinum | 22990-19-8 | Solifenacin medium |
VI, bromohexan-II-unum | 10226-29-6 | Pentoxifylline medium |
Mannose TUBULUS | 92051-23-5 | Precursor of Radiotrater 18fdg ad cellula metabolismus imaging |
1- (IV-chlorophenyl) -1-Phenylethanol | 59767-24-7 | Clemastine medium |
2- (II-chloroethyl) -n-yl-Metrochloride | 56824-22-7 | |
I-methyl-II-Pyrrolidineethanol | 67004-64-2 | Clemastine ABD Udenafil medium |
2- (II-aminoethyl) -1-methylpy | 51387-90-7 | Chloramidine medium et alii |
L-hydroxyyproline | 51-35-4 | |
Echinocandin b | 79411-15-7 | |
Pneumocandinbo | 135575-42-7 | |
D-Glucosamine Hydrochloride | 66-84-2 | |
Pyrromoquinoline Quinone Desodium sal | 122628-50-6 | |
Fr901379 | 144371-88-0 | micafungin medium |
Fr1.19642 | 168110-44-9 | |
Ansiitocin P III | 66547-09-9 | |
Calicheamicin | 113440-58-7 | |
Dactinomycin | 50-76-0 | |
Sam (s-Adenosy-l-methionine) | 200393-05-1 | |
Levulinic acidum | 123-76-2 | |
Ethyl levelinate | 539-88-8 | |
Butyl IV-OXOGENTANOATE | 2052-15-5 | |
Tributyl phosphate | 126-73-8 | |
Triisobutyl phosphate | 126-71-6 | |
triotyl phosphate | 78-42-2 |